Insulin-like Growth Factor-i in acute and chronic malnutrition;Insulin-like Growth Factor-I et dénutrition aiguë ou chronique

Nutrition Clinique et Metabolisme

Volumn 10, Issue 4 SUPPL., 1996, Pages 275-288

  Wolf, Steven E ^a   Ramirez, Roque J ^a   Herndon, David N ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

AIDS; Burn; IGF I; IGFBP; Malnutrition; Postoperative care; Renal failure; Trauma

Indexed keywords

SOMATOMEDIN C;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BURN; HUMAN; INJURY; KIDNEY FAILURE; MALNUTRITION; POSTOPERATIVE CARE; REVIEW;

EID: 0030475212     PISSN: 09850562     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0985-0562(96)80006-9     Document Type: Article

References (113)

1. Aulick H, Wilmore DW. Increased peripheral amino acid release following thermal injury. Surgery 1979 ; 85 : 560-5.
2. Clowes GHA, Randell HT, Cha CJ. Amino acid and energy metabolism in septic and traumatized patients. JPEN 1980 ; 4 : 195-203.
3. Cuthbertson DP. The metabolic response to injury and its nutritional implications: retrospective and prospective. JPEN 1979 ; 3 : 108-30.
4. Moore FD. Bodily changes during surgical convalescence. Ann Surg 1953 ; 137 : 289-95.
5. Kinney JM, Roe CF. Caloric equivalents of fever: patterns of postoperative response. Ann Surg 1962 ; 156 : 610-16.
6. Wilmore DW, Long JM, Mason AD. Catecholamines : mediators of the hypermetabolic response to thermal burn patients. Ann Surg 1974 ; 180 : 653-60.
7. Kitmey N, Long CL, Gump FE, Duke JH. Tissue composition of weight loss in surgical patients. I. Elective Operations. Ann Surg 1968 ; 168 : 459-73.
8. Shaw JH, Wildbore M, Wolfe RR. Whole body protein kinetics in severely septic patients. Ann Surg 1987 ; 205 : 288-95.
9. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987 ; 27 : 262-8.
10. Shils ME. Nutrition and diet in cancer management. In : Shils ME, Olson JA, Shike M editors. Modern nutrition in health and disease. Philadelphia : Lea and Febinger, 1994 : 1317-48.
11. Mordes JP, Rossini AA. Tumor induced anorexia in the Wistar rat. Science 1981 ; 213 : 565-7.
12. Norton JA, Moley JF, Green MV, Carson RE, Morrison SD. Parabiotic transfer of cancer anorexia/cachexia in male rats. Cancer Res 1985 ; 45 : 5547-52.
13. Van Lammeren FM, Chance WT, Fischer JE. Cholecystokinin-induced hypophagia is not potentiated by cancer anorexia. Peptides 1984 ; 5 : 97-101.
14. Chance WT, von Meyenfeldt M, Fischer JE. Serotonin depletion by 5,7-dihydroxy-tryptamine or parachloro-amphetamine does not affect cancer anorexia. Pharmacol Biochem Behav 1983 ; 18 : 115-21.
15. Chance WT, Muggia-Sullam M, Chen MH, Murphy RF, Fischer JE. Reversal of tumor induced biochemical abnormalities by insulin treatment in rats. J Natl Cancer Ins 1986 ; 77 : 497-503.
16. Bartlett DL, Charland SL, Torosian MH. Glucose metabolism and hormone treatment in cancer cachexia. Surg Forum 1991 ; 42 : 14-6.
17. Gelin G, Andersson C, Lundholm K. Effects of indomethacin, cytokines, and ciclosporin A on tumor growth and subsequent development of cancer cachexia. Cancer Res 1991 ; 51 : 880-5.
18. Aisner J, Parnes H, Tait N, Hickman M, Forrest A, Greco FA et al. Appetite stimulation and weight gain with megestrol acetate. Sem Oncol 1990 ; 17 : 2-7.
19. Loprinzi CL, Ellison NM, Goldberg RM, Michalak JC, Burch PA. Alleviation of cancer anorexia and cachexia : studies of the Mayo clinic and North Central Cancer Treatment Group. Sem Oncol 1990 ; 17 : 8-12.
20. Old LJ. Tumor necrosis factor (TNF). Science 1985 ; 230 : 630-2.
21. Scuderi P, Sterling KE, Lam KS, Finley PR, Ryan KJ, Ray CG et al. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet 1986 ; 2 : 1364-5.
22. Lindmark L, Bennegard K, Eden E, Ekman L, Schersten T, Svaninger G et al. Resting energy expenditure in malnourished patients with and without cancer. Gastroenterology 1984 ; 87 : 402-8.
23. Nixon DW, Kuther M, Heymsfleld S, Foltz AT, Carty C, Seitz Q et al. Resting energy expenditure in lung and colon cancer. Metabolism 1988 ; 37 : 1059-64.
24. Douglas RG, Shaw JHF. Metabolic effects of cancer. Brit J Surg 1990 ; 77 : 246-54.
25. Shaw JHF, Humberstone DA, Douglas RG, Koea J. Leucine kinetics in benign disease, non-weight losing cancer, and cancer cachexia: studies at the whole body level and the response to nutritional support. Surgery 1991 ; 109 : 37-50.
26. Flanigan MJ, Lim VS, Redlin J. The significance of protein intake and catabolism. Adv Renal Replacement Ther 1995 ; 2 : 330-405.
27. Weinroth SE, Parenti DM, Simon GL. Wasting syndrome in AIDS : pathogenic mechanisms and therapeutic approaches. Infect Agents Dis 1995 ; 4 : 76-94.
28. Watters JM, Van Woert JH, Wilmore DW. Metabolism and Nutrition. In : Greenfield LJ, Mulholland MW, Oldham KT, Zelenock GB editors. Surgery : Scientific Principles and Practice. Philadelphia : JB Lippincott, 1993 : 38-86.
29. Francis GL, Aplin SE, McNeil KA, Milner SJ, Forbes BE, Ross M et al. Molecular interactions of IGFI and IGF-II with their binding proteins and receptors. In : Baxter RC, Gluckman PD, Rosenfeld RG editors. The Insulin-like Growth Factors and their Regulatory Proteins. New York : Elsevier Science BV, 1994 : 57-66.
30. Lund P, Mots-Staats B, Hynes M, Simmons J, Jansen M, D'Ercole A et al. Somatomedin-C/Insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem 1986 ; 261 : 14539-45.
31. Roberts CT, Lasky SR, Lowe WL, Seaman WT, LeRoith D. Molecular cloning of rat insulin-like growth factor-I complementary deoxyribonucleic acids: Differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol 1987 ; 1 : 243-8.
32. Robinson ICAF. Regulation of growth hormone output: The GRF signal. In : Bercu BB, Walker RF editors. Growth Hormone II : Basic and Clinical Aspects. New York : Springer-Verlag, 1994 : 47-65.
33. Ceda GP, Hoffman A, Silverberg G, Wilson DM, Rosenfeld RG. Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin. J Clin Endocrinol Metab 1985 ; 60 : 1204-8.
34. Strauss DS, Hayden JM, Marten NW. Molecular mechanisms for nutritional regulation of genes for IGF-I, IGF-binding proteins and other plasma proteins. In : Baxter RC, Gluckman PD, Rosenfeld RG editors. The insulin-like growth factors and their regulatory proteins. New York : Elsevier Science BV, 1994 : 33-41.
35. Drop SLS, Brinkman A, Kortleve DJ, Groffen CAH, Schuller A, Zwarthoff EC. The evolution of the insulin-like growth factor binding protein family. In : Spencer EM editor. Modern concepts of insulin-like growth factors. New York : Elsevier, 1991 : 311-28.
36. Spratt SK, Tatsuno GP, Yamanaka M, Ark BC, Detmer J, Mascarenhas D et al. Cloning and expression of human insulin-like growth factor binding protein-3. Growth Factors 1990 ; 3 : 63-72.
37. Baxter RC, Martin JL, Beniac VA. High molecular weight insulin-like growth factor binding protein complex purification and properties of the acid-labile subunit from human serum. J Biol Chem 1989 ; 264 : 11843-48.
38. Hodgkinson SC, Davis SR, Napier JR, Moore LG, Gluckman P. Binding protein activity, biopotency and metabolic clearance of insulin-like growth factor-I variants. Endocrine Society Annual Meeting, Seattle WA, 1989 : 124 (résumé).
39. Ross MM, Miell JP, Holly JMP, Maheshwari H, Norman M, Abdulla AF et al. Levels of growth hormone, insulin-like growth factor binding proteins, insulin, blood glucose and cortisol in intensive care patients. Clin Endocrinol 1991 ; 35 : 361-7.
40. Hawker FH, Stewart PM, Baxter RC, Borkman M, Tan K, Caterson ID et al. Relationship of somatomedin-C/insulin-like growth factor-I levels to conventional nutritional indices in critically ill patients. Crit Care Med 1987 ; 8 : 732-9.
41. Frayn KN, Price DA, Maycock PF, Carrol SM. Plasma somatomedin activity after injury in man and its relationship to other hormonal and metabolic changes. Clin Endocrinol 1984 ; 20 : 179-85.
42. Fleming RYD, Rutan RL, Jahoor F, Barrow RE, Wolfe RR, Herndon DN. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma 1992 ; 32 : 698-703.
43. Clemmons DR, Klibanski A, Underwood LE, McArthur JW, Ridgway EC, Beitins IZ et al. Reduction of plasma immunoreactive somatomedin-C during fasting in humans. J Clin Endocrinol Metab 1981 ; 55 : 999-1002.
44. Maes M, Underwood LE, Ketelslegers JM. Plasma somatomedin-C in fasted and refed rats : close relationship with changes in liver somatogenic (GH) but not lactogenic (PRL) binding sites. J Endocrinol 1983 ; 97 : 243-52.
45. Isley WL, Underwood LE, Clemmons DR. Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content. J Parent Ent Nutr 1984 ; 8 : 407-11.
46. Wojnar MM, Fan J, Frost RA, Gelato MC, Lang CH. Alterations in the insulin-like growth factor system in trauma patients. Am J Physiol 1995 ; 268 : R970-7.
47. Jeevanandam M, Holaday NJ, Petersen SR. Post-traumatic hormonal environment during total parenteral nutrition. Nutrition 1993 ; 9 : 333-8.
48. Jeevanandanm M, Holaday NJ, Petersen SR. Plasma levels of insulin-like growth factor binding protein in acute trauma patients. Metabolism 1995 ; 44 : 1205-8.
49. Fan J, Char D, Kolasa AJ, Pan W, Maitra SR, Patlak CS et al. Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin. Am J Physiol 1995 ; 268 : E33-42.
50. Jeevanandam M, Holaday NJ, Petersen SR. Ajuvant recombinant human growth hormone does not augment endogenous glucose production in total parenteral nutrition-fed multiple trauma patients. Metabolism 1996 ; 45 : 450-6.
51. Melarvie S, Jeevanandam M, Holaday NJ, Petersen SR. Pulsatile nature of growth hormone levels in critically ill trauma victims. Surgery 1995 ; 117 : 402-8.
52. Ghahary A, Fu S, Shen YJ, Shankowsky HA, Tredget EE. Differential effects of thermal injury on circulating insulin-like growth factor binding proteins in burn patients. Mol Cell Biochem 1994 ; 135 : 171-80.
53. Herndon DN, Curreri RW, Abston S, Rutan RC, Barrow RE. Treatment of burns. Current Problems in Surgery 1987 ; 2 : 347-73.
54. Wolfe RR. Nutrition and metabolism in burns. Crit Care Med 1986 ; 7 : 19-23.
55. Nygren J, Sammann M, Malm M, Efendic S, Hall K, Brismar K et al. Disturbed anabolic hormonal patterns in burned patients: the relation to glucagon. Clin Endocrinol 1995 ; 43 : 491-500.
56. Møller S, Jenson M, Svensson P, Skakkebék NE. Insulin-like growth factor-I (IGF-I) in burn patients. Burns 1991 ; 17 : 279-81.
57. Kagan RJ. The effect of burn wound size on ureagenesis and nitrogen balance. Ann Surg 1982 ; 195 : 70-6.
58. Demling RN. Burns. N Engl J Med 1985 ; 313 : 1389-93.
59. Abribat T, Brazeau P, Davignon I, Garrel DR. Insulin-like gowth factor-I blood levels in severely burned patients: effects of time post injury, age of patient and severity of burn. Clin Endocrinol 1993 ; 39 : 583-9.
60. Hill GL, Blackett RL, Pickford I. Malnutrition in surgical patients, an unrecognized problem. Lancet 1977 ; i : 689-92.
61. Windsor JA, Hill GL. Weight loss with physiologic impairment, a basic indicator of surgical risk. Ann Surg 1988 ; 207 : 290-6.
62. Dempsey DT, Mullen JL, Buzby GP. The link between nutritional status and clinical outcome: can nutritional intervention modify it ? Am J Clin Nutr 1988 ; 47 (Suppl 2) : 352-6.
63. The Veterans Affairs Total Patenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991 ; 325 : 525-32.
64. Shaw JHF, Wildbore M, Wolfe RR. Whole body protein kinetics in severely septic patients. The response to glucose infusion and total parenteral nutrition. Ann Surg. 1986 ; 205 : 288-94.
65. Shaw JHF. The influence of stress, depletion and/or malignant disease on the responsiveness of surgical patients to total parenteral nutrition. Am J Clin Nutr 1988 ; 48 : 144-7.
66. Koea JB, Gallaher BW, Breier BH. Passive immunization against circulating insulin-like growth factor-I (IGF-I) increases protein catabolism in lambs : evidence for a physiologic role for circulating IGF-I. J Endocrinol 1993 ; 135 : 279-84.
67. Douglas RG, Gluckman PD, Ball KT, Breier BH, Shaw JHF. The effects of IGF-I infusion on glucose and protein metabolism in starving lambs. J Clin Invest 1991 ; 88 : 614-22.
68. Koea JB,Douglas RG, Shaw JHF, Gluckman PD. Growth hormone therapy initiated before starvation ameliorates the catabolic state and enhances the protein-sparing effect of total parenteral nutrition. Brit J Surg 1993 ; 80 : 740-4.
69. Kopple JD, Ding H, Gao XL. Altered physiology and action of insulin-like growth factor-I in skeletal muscle in chronic renal failure. Am J Kidney Dis 1995 ; 26 : 248-55.
70. Ding H, Gao XL, Hirschberg R, Vadgama JV, Kopple JD. Impaired actions of insulin-like growth factor-I on protein synthesis and degredation in skeletal muscle of rats with chronic renal failure. Evidence for a post-receptor defect. J Clin Invest 1996 ; 97 : 1064-75.
71. Sanaka T, Shinobe M, Ando M, Hizuka N, Kawaguchi H, Nihei H. IGF-I as an early indicator of malnutrition in patients with end-stage renal disease. Nephron 1994 ; 67 : 73-81.
72. Fouque D, Le Bouc Y, Laville M, Combarnous F, Joly MO, Raton P et al. Insulin-like growth factor-I and its binding proteins during a low-protein diet in chronic renal failure. J Am Soc Nephrol 1995 ; 6 : 1427-33.
73. Fouque D, JoIy MO, Laville M, Beaufrère B, Goudable J, Pozet N et al. Increase in circulating insulin-like growth factor-I in chronic renal failure is reduced by low protein diet. Mineral Electrolyte Metab 1992 ; 18 : 276-9.
74. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993 ; 77 : 956-62.
75. Leiberman SA, Butterfield GE, Harrison D, Hoffman AR. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1994 ; 78 : 404-10.
76. Petersen SR, Jeevanandam M, Holaday NJ. Adjuvant recombinant human growth hormone stimulates insulin-like growth factor binding protein-3 secretion in critically ill trauma patients. J Trauma 1995 ; 39 : 295-300.
77. Petersen SR, Voerman BJ, Strack van Schijndel RJ, de Boer H, Groeneveld AB, Nauta JP et al. Effects of human growth hormone on fuel utilization and mineral balance in critically ill patients on full intravenous nutritional support. J Crit Care 1994 ; 9 : 143-50.
78. Behrman SW, Kudsk KA, Brown RO, Vehe KL, Wojtysiak SL. The effect of growth hormone on nutritional markers in enterally fed immobilized trauma patients. JPEN 1995 ; 19 : 41-6.
79. Roth E, Valentini L, Semsroth M, Holzenbein T, Winkler S, Blum WF et al. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. J Trauma 1995 ; 38 : 136-41.
80. Voerman HJ, van Schijndel RJM, Groeneveld ABJ et al. Effects of recombinant human growth hormone in patients with severe sepsis. Ann Surg 1992 ; 216 : 648-55.
81. Jeevanandam M, Petersen SR. Altered lipid kinetics in adjuvant recombinant human growth hormone treated multiple trauma patients. Am J Physiol 1994 ; 267 : E560-5.
82. Jurasinski CV, Vary TC. Insulin-like growth factor-I accelerates protein synthesis in skeletal muscle during sepsis. Am J Physiol 1995 ; 269 : E977-81.
83. Liljedahl SO, Gemzell CA, Plantin LO, Birke G. Effect of human growth hormone in patients with severe burns. Acta Chir Scand 1961 ; 22 : 1-14.
84. Soroff HS, Rozin RR, Mooty J, Lister J, Raben MS. Role of human growth hormone in the response to trauma: I. Metabolic effects following burns. Ann Surg 1967 ; 166 : 739-52.
85. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor site healing in severely burned children. Ann Surg 1990 ; 212 : 424-31.
86. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on whole body and isolated limb protein kinetics in burned patients. Arch Surg 1991 ; 126 : 38-43.
87. Herndon DN, Hawkins HK, Nguyen TT, Pierre E, Cox R, Barrow RE. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 1995 ; 221 : 649-59.
88. Strock LL, Singh H, Abdullah A, Miller JA, Herndon DN. The effect of insulin-like growth factor-I in post burn hypermetabolism. Surgery 1990 ; 108 : 161-4.
89. Cioffi WG, Gore DC, Rue LC, Carrougher G, Guler HP, McManus WF et al. Insulin-like growth factor-I lowers protein oxidation in patients with thermal injury. Ann Surg 1994 ; 220 : 310-9.
90. Pointing GA, Halliday D, Teale JD, Sim AJW. Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone. Lancet 1988 ; 1 : 438-9.
91. Tacke J, Bolder U, Lohlein D. Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery. Infusionstherapie und Transfusionsmedizen 1994 ; 21 : 24-9.
92. Sandstrom R, Svanberg E, Hyltander A, Haglind E, Ohlsson C, Zachrisson H et al. The effect of recombinant human IGF-I on protein metabolism in postoperative patients without nutrition compared to effects in experimental animals. Eur J Clin Invest 1995 ; 25 : 784-92.
93. Miell JP, Taylor AM, Jones J, Buchanan CR, Rennie J, Sherwood R et al. Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery. Clin Endocrinol 1992 ; 37 : 542-51.
94. Goeters C, Mertes N, Tacke J, Bolder J, Kuhmann M, Lawin P et al. Repeated administration of recombinant human insulin-like growth factor-I in patients after gastric surgery. Ann Surg 1995 ; 222 : 646-53.
95. Miller SB, Martin DR, Kissane J, Hammerman MR. Insulin-like growth factor-I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 1992 ; 89 : 11876-80.
96. Ding H, Kopple JD, Cohen A, Hirschberg R. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic tubular necrosis. J Clin Invest 1993 ; 91 : 2281-7.
97. Tayek JA, Brasel JA. Failure of anabolism in malnourished cancer patients receiving growth hormone: a clinical research center study. J Clin Endocrinol Metab 1995 ; 80 : 2082-7.
98. Ng B, Wolf RF, Weksler B, Brennan MF, Burt M. Growth hormone administration preserves lean body mass in sarcoma bearing animals treated with doxorubicin. Cancer Res 1993 ; 53 : 5483-6.
99. Ng EH, Rock CS, Lazarus DD, Staiano-Coico L, Moldawer LL, Lowry SF. Insulin-like growth factor-I preserves host lean tissue mass in cancer cachexia. Am J Physiol 1992 ; 262 : R426-31.
100. Lazarus DD, Kambayashi T, Lowry SF, Strassmann G. The lack of an effect by insulin or insulin-like growth factor-I in attenuating colon-2-mediated cancer cachexia. Cancer Letters 1996 ; 103 : 71-7.
101. Tomas FM, Chandler CS, Coyle P, Bourgeois CS, Burgoyne JL, Rofe AM. Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumor-bearing rats. Biochem J 1994 ; 301 : 769-75.
102. O'Shea MH, Miller SB, Hammerman MR. Effects of IGF-I on renal function in patients with chronic renal failure. Am J Physiol 1993 ; 264 : F917-22.
103. Miller SB, Moulton M, O'Shea M, Hammerman MR. Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney Int 1994 ; 46 : 201-07.
104. Hazel SJ, Gillespie CM, Moore RJ, Clark RG, Jureidini KF, Martin AA. Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. Kidney Int 1994 ; 46 : 58-68.
105. Martin AA, Tomas FM, Ballard FJ, Read LC. Insulin-like growth factor-I and its variant, des (1-3)IGF-I, improve nitrogen balance and food utilization in rats with renal failure. Mineral Electrolyte Metab 1992 ; 18 : 264-8.
106. Clark R, Mortensen D, Rabkin R. Recovery from acute ischemic renal failure is accelerated by des-(1-3)-insulin-like growth factor-I. Clin Sci 1994 ; 86 : 709-14.
107. Silbergeld A, Klinger B, Keret R, Eshet R, Almonte AS, Laron Z. Serum growth hormone-binding protein (GHBP) administration of insulin-like growth factor-I in three Laron syndrome siblings with normal GHBP. Proc Soc Exp Biol Med 1994 ; 206 : 324-7.
108. 2-induced acute renal failure: the effects on renal IGF-I, IGF-I receptor and IGF-binding protein-1 mRNA. J Am Soc Nephrol 1995 ; 5 : 1782-91.
109. Ikizler TA, Wingard RL, Hakim RM. Interventions to treat malnutrition in dialysis patients: the role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone. Am J Kidney Dis 1995 ; 26 : 256-65.
110. Kopple JD, Ding H, Gao XL. Altered physiology and action of insulin-like growth factor-I in skeletal muscle in chronic renal failure. Am J Kidney Dis 1995 ; 26 : 248-55.
111. Blake PG. Growth hormone and malnutrition in dialysis patients. Peritoneal Dialysis International. 1995 ; 15 : 210-6.
112. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993 ; 77 : 956-62.
113. Krentz AJ, Koster FT, Crist DM, Finn K, Johnson LZ, Boyle PJ et al. Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J AIDS 1993 ; 6 : 245-51.